Clinico-Pathological Significance of Tumor Infiltrating Immune Cells in Oral Squamous Cell Carcinoma-Hope or Hype?

被引:0
|
作者
Seenivasagam, Rajkumar K. [1 ,2 ]
Singh, Ashok [3 ]
Gowda, Vinay N. [3 ,4 ]
Poonia, Dharma R. [2 ,5 ]
Majumdar, Kinjal S. [2 ,6 ,7 ,8 ]
Abhinav, Thaduri [2 ,8 ,9 ]
Kaul, Pallvi [2 ,8 ,10 ]
Panuganti, Achyuth [2 ,8 ,11 ]
Kailey, Vikramjit S. [8 ,12 ]
Kumar, Rahul [2 ]
Chowdhury, Nilotpal [3 ]
机构
[1] PSG Inst Med Sci & Res, Dept Surg Oncol, Coimbatore, India
[2] All India Inst Med Sci, Dept Surg Oncol, Rishikesh, India
[3] All India Inst Med Sci, Dept Pathol, Rishikesh, India
[4] All India Inst Med Sci, Dept Pathol & Lab Med, Jodhpur, India
[5] All India Inst Med Sci, Dept Surg Oncol, Jodhpur, India
[6] Kasturba Med Coll & Hosp, Dept ENT Head & Neck Surg, Manipal 576119, India
[7] Manipal Acad Higher Educ, Manipal, India
[8] All India Inst Med Sci, Dept Otolaryngol & Head & Neck Surg, Rishikesh, Uttaranchal, India
[9] Mediciti Inst Med Sci, Dept ENT, Warangal, India
[10] Shri Guru Ram Rai Inst Med & Hlth Sci, Dept Surg Oncol, Dehra Dun, India
[11] Mediciti Inst Med Sci, Dept ENT, Ghanpur, India
[12] Mohandai Oswal Hosp, Ludhiana, India
来源
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK | 2025年
关键词
Oral cancer; squamous cell carcinoma; tumor-associated macrophages; tumor-infiltrating lymphocytes; tumor microenvironment; CANCER; NECK; HEAD; PATHOLOGISTS; IMMUNOSCORE; LYMPHOCYTES; HALLMARKS; TILS;
D O I
10.1002/hed.28083
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
BackgroundTo correlate between immunohistochemical expression of tumor-infiltrating lymphocytes (TILs), tumor-associated macrophages (TAMs), and natural killer (NK) cells with the AJCC 8th edition TNM staging system and other disease-modifying clinico-pathological variables.MethodsThe representative histology sections of tumor invasive margin (IM) and tumor core (TC) were selected according to the International Immuno-Oncology Biomarker Working Group and were subjected to immunohistochemistry with antibodies for TILs (CD3, CD8, FOXP3), NK Cells (CD57), TAMs (CD68, CD163) and pan-leukocyte marker (CD45). Histo-immuno-density-intensity (HIDI) scoring was calculated as a product of the proportion and intensity of staining. Ordinal-ordinal and continuous-ordinal variables were correlated using Kendall's tau-b (tau b), and binary-ordinal variables were correlated using Rank-Biserial (rrb) statistics.ResultsA total of 111 patients were included in the study. None of the clinical and pathological parameters showed a strong correlation with any of the immune infiltrates including TNM staging.ConclusionWe hypothesize an independent activity of tumor immunology in the disease prognosis.Trial RegistrationCTRI/2020/07/026335
引用
收藏
页数:11
相关论文
共 50 条
  • [31] Clinico-pathological features of oral squamous cell carcinoma and oral potentially malignant disorders: A comparative study from a tertiary care hospital of Karachi
    Khan, Samreen
    Alamgir, Muhammad Mohiuddin
    Bukhari, Uzma
    Farrukh, Muhammad Shuja
    Qurat-Ul-Ain
    Shafiq, Areeba
    JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION, 2025, 75 (03) : 443 - 446
  • [32] Pathological tumor volume predicts survival outcomes in oral squamous cell carcinoma
    Mukoyama, Nobuaki
    Suzuki, Hidenori
    Hanai, Nobuhiro
    Sone, Michihiko
    Hasegawa, Yasuhisa
    ONCOLOGY LETTERS, 2018, 16 (02) : 2471 - 2477
  • [33] Transcriptomic and Immunophenotypic Characterization of Tumor Immune Microenvironment in Squamous Cell Carcinoma of the Oral Tongue
    Chatzopoulos, Kyriakos
    Sotiriou, Sotiris
    Collins, Andrea R.
    Kartsidis, Panagiotis
    Schmitt, Alessandra C.
    Chen, Xianfeng
    Khazaie, Khashayarsha
    Hinni, Michael L.
    Ramsower, Colleen A.
    Zarka, Matthew A.
    Patel, Samir H.
    Garcia, Joaquin J.
    HEAD & NECK PATHOLOGY, 2021, 15 (02) : 509 - 522
  • [34] Tumor-infiltrating plasma cells are the promising prognosis marker for esophageal squamous cell carcinoma
    Yao, Chengyun
    Yu, Hongliang
    Zhou, Guoren
    Xu, Jianhua
    Gu, Dayong
    Yin, Li
    He, Xia
    Xia, Hongping
    ESOPHAGUS, 2021, 18 (03) : 574 - 584
  • [35] The pathological significance of Notch1 in oral squamous cell carcinoma
    Yoshida, Ryoji
    Nagata, Masashi
    Nakayama, Hideki
    Niimori-Kita, Kanako
    Hassan, Wael
    Tanaka, Takuji
    Shinohara, Masanori
    Ito, Takaaki
    LABORATORY INVESTIGATION, 2013, 93 (10) : 1068 - 1081
  • [36] Tumor-Infiltrating CD45RO+ Memory Cells Are Associated with Favorable Prognosis in Oral Squamous Cell Carcinoma Patients
    Ito, Nanako
    Yamasaki, Sachiko
    Shintani, Tomoaki
    Matsui, Kensaku
    Obayashi, Fumitaka
    Koizumi, Koichi
    Tani, Ryouji
    Yanamoto, Souichi
    Okamoto, Tetsuji
    CANCERS, 2023, 15 (08)
  • [37] Prognostic and clinicopathological significance of PD-L1 and tumor infiltrating lymphocytes in hypopharyngeal squamous cell carcinoma
    Hu, Chunyan
    Tian, Shu
    Lin, Lan
    Zhang, Jiahao
    Ding, Hao
    ORAL ONCOLOGY, 2020, 102
  • [38] Immune signature of tumor-infiltrating immune cells predicts the prognosis and therapeutic effects in squamous cell carcinoma
    Che, Yun
    Luo, Zhiwen
    Zhang, Chaoqi
    Sun, Nan
    Gao, Shugeng
    He, Jie
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2020, 87
  • [39] Expression of pro-inflammatory protein, iNOS, VEGF and COX-2 in Oral Squamous Cell Carcinoma (OSCC), relationship with angiogenesis and their clinico-pathological correlation
    Sappayatosok, Kraisorn
    Maneerat, Yaowapa
    Swasdison, Somporn
    Viriyavejakul, Parnpen
    Dhanuthai, Kittipong
    Zwang, Julien
    Chaisri, Urai
    MEDICINA ORAL PATOLOGIA ORAL Y CIRUGIA BUCAL, 2009, 14 (07): : E319 - E324
  • [40] The repertoire of tumor-infiltrating lymphocytes within the microenvironment of oral squamous cell carcinoma reveals immune dysfunction
    Hongzhi Quan
    Zhongyan Shan
    Ziyi Liu
    Sixuan Liu
    Liu Yang
    Xiaodan Fang
    Kun Li
    Baisheng Wang
    Zhiyuan Deng
    Yanjia Hu
    Zhigang Yao
    Junhui Huang
    Jianjun Yu
    Kun Xia
    Zhangui Tang
    Liangjuan Fang
    Cancer Immunology, Immunotherapy, 2020, 69 : 465 - 476